The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro and Lipedema — What UK Patients Need to Know
Lipedema is a chronic condition causing abnormal fat accumulation, typically in the legs and lower body, often accompanied by pain and swelling. Many people with lipedema also experience excess weight, which can worsen symptoms. Mounjaro (tirzepatide) is a prescription-only weight management injection licensed in the UK that may help support weight loss when combined with lifestyle changes. However, understanding how Mounjaro relates specifically to lipedema, and what NHS support is available, requires careful consideration. This guide covers UK prescribing context, eligibility, and what you should discuss with your GP.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Lipedema, Weight, and Mounjaro — NHS Context
Lipedema is a condition affecting fat distribution and is distinct from simple obesity, though weight management may still be beneficial for symptom relief and mobility. Lipedema primarily affects subcutaneous fat (fat under the skin), particularly in the legs, and is often underdiagnosed in the UK. Weight loss alone does not supports lipedema, but reducing overall body weight may help reduce pain, improve mobility, and decrease swelling severity.
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist approved for weight management in UK adults with a BMI of 30 or above, or BMI 27–29.9 with weight-related health conditions. If you have lipedema and excess weight, Mounjaro may be considered as part of a comprehensive weight management approach. However, lipedema itself is not typically listed as a standalone indication for Mounjaro prescribing.
- Weight loss of 10–15% body weight may help reduce lipedema-related symptoms
- Mounjaro works alongside reduced-calorie diet and increased physical activity
- Individual responses vary significantly
- A UK-licensed prescriber must assess your suitability for treatment
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
NHS Access to Mounjaro for Lipedema — What to Expect
NHS access to Mounjaro is through specialist tier 3 weight management services, typically requiring a referral from your GP. If you have lipedema, ask your GP to refer you to your local specialist weight management service. The service will assess whether Mounjaro is appropriate based on your BMI, overall health, and weight-related complications.
Alternatively, Mounjaro is available privately through UK-licensed online prescribers following a clinical assessment — this route does not require NHS referral. Private prescribing offers faster access but involves out-of-pocket costs. Regardless of route, your prescriber will need to confirm that you meet eligibility criteria and that Mounjaro is safe for you personally. Use our free BMI calculator to check your current BMI and understand your starting point before discussing options with your GP.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Does Mounjaro supports lipedema?
No. Mounjaro is not a supports for lipedema. It may support weight loss, which can help reduce pain and swelling associated with lipedema, but the underlying condition remains. Lipedema requires a multidisciplinary approach including weight management, compression therapy, lymphatic drainage, and specialist physiotherapy.
Is lipedema a reason to be prescribed Mounjaro on the NHS?
Lipedema alone is not a standard NHS indication for Mounjaro. However, if you have lipedema and also meet BMI eligibility criteria (BMI 30+, or 27–29.9 with weight-related health conditions), you may be eligible for Mounjaro through NHS specialist services. Your GP and specialist team will assess your individual circumstances.
How much weight loss can I expect with Mounjaro if I have lipedema?
Clinical trials showed average weight loss of 15–21% of body weight over 72 weeks. Individual results vary significantly based on dose, adherence, diet, and physical activity. Weight loss with lipedema may be slower than in people without lipedema, as the condition affects fat distribution differently.
Can I get Mounjaro privately for lipedema without NHS referral?
Yes. Private UK-licensed online prescribers can assess you and issue prescriptions if you meet clinical criteria. This does not require NHS referral but does involve out-of-pocket costs. A UK prescriber will assess your lipedema history, current weight, and overall health before deciding if Mounjaro is suitable.
What other treatments should I consider alongside Mounjaro for lipedema?
A comprehensive lipedema management plan typically includes compression garments, a UK pharmacy lymphatic drainage, specialist physiotherapy, and dietary support. If you are prescribed Mounjaro, these treatments should continue alongside medication. Ask your GP for a referral to a lipedema specialist or vascular clinic for full assessment.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.